Shandong Lukang Pharmaceutical Co.,Ltd. (SHA:600789)

China · Delayed Price · Currency is CNY

7.38

+0.07 (0.96%)

Jul 29, 2026, 3:00 PM CST

SHA:600789 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	5,709	5,766	6,233	6,147	5,621	4,924
Revenue Growth	-6.54%	-7.49%	1.41%	9.34%	14.17%	17.09%
Gross Profit	1,225	1,227	1,427	1,461	1,206	1,147
Operating Income	213.16	194.89	316.74	266.14	194.06	143.37
Net Income	86.96	112.3	394.62	246.17	138.01	89.1
Earnings Per Share	0.09	0.12	0.44	0.28	0.15	0.10
EPS Growth	-80.30%	-72.73%	57.14%	86.67%	50.00%	-60.00%

Revenue by Geography

Fiscal Year	FY 2025
Period Ending	Dec '25 Dec 31, 2025
China	4,561
Foreign	1,149
Total	5,710

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	2,110	2,344	773.76	799.65	690.07	578.06
Total Debt	2,648	3,069	2,840	2,876	2,854	2,649
Net Cash (Debt)	-538.31	-725.14	-2,066	-2,076	-2,164	-2,071
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-0.55	-0.77	-2.30	-2.36	-2.35	-2.32

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	835.43	698.17	402.82	604.01	444.38	177.49
Capital Expenditures	-331.68	-338.86	-279.18	-337.91	-428.36	-488.57
Free Cash Flow	503.75	359.31	123.64	266.09	16.02	-311.07
Free Cash Flow Growth	1900.13%	190.62%	-53.54%	1561.36%	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	21.46%	21.28%	22.89%	23.77%	21.45%	23.29%
Operating Margin	3.73%	3.38%	5.08%	4.33%	3.45%	2.91%
Pretax Margin	2.49%	2.80%	6.96%	4.44%	2.67%	2.31%
Profit Margin	1.52%	1.95%	6.33%	4.00%	2.46%	1.81%
FCF Margin	8.82%	6.23%	1.98%	4.33%	0.29%	-6.32%

Dividends

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 29, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Dividend Per Share	0.050	0.050	0.132	0.090	0.050	0.050
Dividend Per Share Growth	-62.12%	-62.12%	46.67%	80.00%	0%	-9.09%
Dividend Yield	0.68%	0.56%	1.41%	1.30%	0.72%	0.70%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 29, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	83.49	84.13	21.75	25.84	46.50	74.00
P/FCF Ratio	15.31	26.30	69.42	23.91	400.72	-
PS Ratio	1.35	1.64	1.38	1.03	1.14	1.34